Geode Capital Management
OACC

Geode Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Geode Capital Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$162K Hold
15,243
– – ﹤0.01% 3990
2025
Q4 		$162K Hold
15,243
– – ﹤0.01% 3981
2025
Q3 		$160K Buy
+15,243
New +$159K ﹤0.01% 3995

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Geode Capital Management's OACC Position: Q1 2026 in Review

Geode Capital Management held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q1 2026 at 15,243 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #3990.

Geode Capital Management first reported a position in OACC in Q3 2025 and has held it in 3 quarters since. The position peaked at $162K in Q4 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Geode Capital Management held 15,243 shares of Oaktree Acquisition Corp III Life Sciences worth $162K as of Q1 2026.
  • Geode Capital Management left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3990 holding.
  • Geode Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • Geode Capital Management's Oaktree Acquisition Corp III Life Sciences position peaked at $162K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.